Grant name: Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Funding organization: National Institutes of Health (NIH), National Cancer Institute (NCI)
Total funding amount: Up to $225,000 per year
Duration: Maximum of three years
Primary objective: Facilitate well-planned clinical trials across the cancer prevention and control spectrum
Funding source: NIH
Significance: Addresses critical information gaps in cancer trials
Grant frequency: Recurring
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized and Other)
Federal Governments
U.S. Territories or Possessions
Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Faith-based or Community-based Organizations
Regional Organizations
Foreign Organizations
Cancer prevention and interception
Cancer screening
Early detection
Behavioral research in cancer prevention and control
Implementation science
Healthcare delivery
Cancer survivorship
Supportive and palliative care
Quality of Life (QOL)
Applicants must have the skills, knowledge, and resources necessary to carry out the proposed research.
Application budgets are limited to $225,000 per year and $450,000 in direct costs over the 3-year project period without a clinical trial.
Applications that include a pilot/feasibility clinical trial are limited to $225,000 per year and $600,000 in direct costs over the 3-year project period.
Next application deadline: June 25, 2025
All applications are due by 5:00 PM local time of applicant organization.
All applicants must comply with NIH Grants Policy Statement and other applicable federal regulations.
Applications must follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications that are first-in-human studies or that only propose to write a protocol or manual will be deemed non-responsive.